top of page

Please contact us if you have questions about PeriphaGen, the NET platform, or PGN-503, or are interested in discussing collaboration


If you have any general questions about our platform technology, drug candidates, upcoming clinical trials, would like to request any reprints, or would like more information concerning the company, please contact us using the form below.

Our contact information is:

PeriphaGen, Inc.

2403 Sidney Street

Suite 255
Pittsburgh, PA


Success! Message received.

PeriphaGen is interested in speaking with potential corporate (pharma) partners as well as investors.  We are interested in partnering our development programs especially for major markets outside the U.S, including Asia and Europe.  If you are interested in partnering (business development) or would like more information, please contact us via the form below.

Success! Message received.


We have designed, constructed, grown and purified HSV-based vectors for other investigators both under a collaborative research agreement or under a contract service agreement. If you are interested in collaborating or wondering how our gene delivery platform could be helpful in addressing your basic research, applied research, or clinical needs, please contact us using the form below. 

Success! Message received.

bottom of page